Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway

BACKGROUND: Multiple myeloma (MM) is the most common malignant hematological disease in the people worldwide. Glaucocalyxin A (GLA) is a bioactive ent-kauranoid diterpenoid, that is derived from Rabdosia japonica var. GLA has been demonstrated that it had various pharmacological activities, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mei, Chen, Cailong, Wang, Qian, Jiang, Xiaolu, Tan, Lanlan, Huang, Ying, Zhang, Yan, Zhang, Zubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684694/
https://www.ncbi.nlm.nih.gov/pubmed/34923957
http://dx.doi.org/10.1186/s12935-021-02375-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684694/
https://www.ncbi.nlm.nih.gov/pubmed/34923957
http://dx.doi.org/10.1186/s12935-021-02375-z

Ejemplares similares